SDS Biotech K.K.
株式会社エス・ディー・エス バイオテック
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4952
No filings in 18+ monthsFY2020 (Mar 2021) · J-GAAP · parent-only (non-consolidated) Source: filing S100LNTP
FY = fiscal year, named by the calendar year it starts in; the month in brackets is when it ends (FY2025 ends Mar 2026 for a March year-end). FY2020 (Mar 2021) runs Apr 1, 2020 – Mar 31, 2021.
| Gross margin | 36.7% |
|---|---|
| Operating margin | 10.3% |
| Net margin | 11.4% |
| Return on equity | 18.7%Includes one-off items (e.g. gains on negative goodwill) |
| Return on assets | 9.3% |
| Revenue growth (YoY) | -3.1% |
| EPS (basic) | ¥175.14 |
| EPS growth (YoY) | 15.5% |
| Current ratio | 2.53x |
| Equity ratio | 52.5% |
| Book value / share | ¥1,020.15 |
| Free cash flow | ¥1.7B |